Filter
36
Text search:
adenovirus
Featured
Recommendations
5
New Publications
4
Language
Document type
Guidelines
12
No document type
9
Studies & Reports
4
Manuals
3
Training Material
3
Situation Updates
2
Resource Platforms
1
Videos
1
Fact sheets
1
Countries / Regions
Germany
2
Argentina
2
Brazil
2
Western and Central Europe
2
Africa
2
Rwanda
1
Bangladesh
1
Colombia
1
Myanmar / Burma
1
Paraguay
1
Venezuela
1
Russia
1
Global
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
12
Clinical Guidelines
4
Key Resources
3
Public Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
16
TB
4
Ebola & Marburg
2
Cholera
1
Rapid Response
1
HIV
1
Mental Health
1
AMR
1
Caregiver
1
Planetary Health
1
2.0 Rapid Response
1
Learn about the composition and delivery mechanism for the new classes of COVID-19 vaccines based on adenovirus from Johnson & Johnson and AstraZeneca with Dr. Jonathan Genzen, COO of ARUP Laboratories and an Associate Professor at the University of
...
Ausgabe 2015 (kommentierte Version); gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz - IfSG
In dieser Version sind die wichtigsten Änderungen zur Vorversion der Falldefinitionen markiert und durch Randnotizen erläuter
...
gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von
Infektionskrankhei ten beim Menschen (Infektionsschutzgesetz - I fSG)
Ficha de Notificación e Investigación Epidemiológica Hepatitis Aguda Grave de origen Desconocido
Actualizatión 16.05.2022
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
Vaccinator's Manual. CONVIDECIA Vaccine
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
In this review, the editors will investigate the impact of eight WASH interventions in preventing (reducing the risk of) and controlling outbreaks in LMIC, with particular focus on three diseases of current concern to the response community – cholera, Ebola, and Hepatitis E. Additionally, we will
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
El presente documento de trabajo fue elaborado en el marco de una investigación bibliográfica participativa y la experiencia acumulada por los técnicos de las áreas involucradas en la respuesta a las Infecciones Respiratorias Agudas (IRA) .
El documento constituye una guía orientativa de trab
...
Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force
